How to Turn $10,000 into $260,000!

05-02-dividendsWelcome to another episode of Wall Street Unplugged!

My guest this week is longtime friend, Marc Lichtenfeld, Chief Income Strategist at the Oxford Club.

Marc joins me in talks about perpetual dividend raisers and the absolute fortune investors can make by compounding dividends over long periods. He also shares one of his secrets to buying some of the best high-yielding companies at dirt cheap prices.

[app_audio src=”″]

Marc then breaks down the biotech sector, an industry he’s covered for years. He talks about one specific area that holds huge promise to discovering cures for cancer, Alzheimer’s and Parkinson’s disease.

Also, he shares with us his favorite small-cap biotech name to buy right now.

Don’t miss out on this week’s educational segment covering some unique technologies investors need to be aware of. Discussed is a sector already having a tremendous affect on patients, significantly extending the lives of the unfortunate and elderly.

As always, thank you for tuning in and good investing!

Links & Resources

  • Stay updated with Marc Lichtenfeld here on his site
  • Discover some of Marc’s most recent podcasts on Itunes here
  • Mentioned interview with former DEA agent Robert Mazur
  • Mentioned interview with Frank Abagnale Jr.
  • Marc’s book, Get Rich with Dividends

Stocks Mentioned

  • Chipotle (CMG)
  • 3M (MMM)
  • Hewlett Packard (HPQ)
  • International Business Machines (IBM)
  • Gap (GPS)
  • Darden Restaurants (DRI)
  • Biogen Inc. (BIIB)
  • Amgen Inc. (AMGN)
  • Intel Corporation (INTC)
  • Bio-tech ETF (IBB)
  • GW Pharmaceuticals (GWPH)
  • Foundation Medicine (FMI)
  • Illumina Inc. (ILMN)
  • Pfizer (PFE)
  • Bristol-Myers Squibb (BMY)
  • Prana Biotechnology (PRAN)
  • Corbus Pharmaceuticals (CRBP)
  • Pluristem Therapeutics (PSTI)
  • Brainstorm Cell Therapeutics (BCLI)
  • BioTime (BTX)


Section 232 uranium

What to expect from the Section 232 decision

As the Section 232 uranium decision deadline looms… Jeff Klenda, CEO of Ur-Energy, returns to the podcast to give his take on how it’ll all…
Listen Now
technical analysis

How to use technical analysis to make money in this market

Rich Suttmeier is founder and CEO of Global Market Consultants—and the newest contributing editor at Curzio Research. He’s an excellent analyst with 40 years of…
Listen Now